Evaluation of a bromine-76-labeled progestin 16α,17α-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies☆
To access this article, please choose from the options below
☆ This work was supported by the DOE (DE FG02 86ER60401 to JAK and DE FG02-84ER-60218 to MJW) and the NIH (PHS 2R01 CA25836 to JAK).
PII: S0969-8051(08)00108-X
doi:10.1016/j.nucmedbio.2008.05.001
© 2008 Elsevier Inc. All rights reserved.
